HomeEmerging MarketsAnthony Pompliano's ProCap Buys...

Anthony Pompliano’s ProCap Buys Over 3,700 Bitcoin—What’s Driving The Aggressive Bet?

Anthony Pompliano‘s ProCap BTC, LLC purchased 3,724 Bitcoin BTC/USD within 24 hours of announcing a $1 billion business combination and over $750 million in fundraising, according to a press release on Tuesday.

The Bitcoin was acquired at a time-weighted average price (TWAP) of $103,785 per Bitcoin.

The acquisition follows ProCap’s June 23 announcement of its planned merger with Columbus Circle Capital Corp. I CCCM, a deal that would take ProCap public under the name ProCap Financial, Inc.

The transaction also positions the company to expand its Bitcoin holdings significantly, with plans to potentially hold up to $1 billion worth of Bitcoin on its balance sheet following the merger’s completion.

ProCap confirmed that the Bitcoin purchase was part of its ongoing strategy to accumulate bitcoin as a core balance sheet asset.

Also Read: Wealthy Investors Want Crypto Advice But Doubt Their Advisors’ Experience: Report

The company’s immediate deployment of capital gives its equity investors exposure to Bitcoin from the outset.

ProCap BTC, LLC, a Bitcoin-focused financial services firm, was founded by Pompliano, a long-time Bitcoin advocate and investor in over 300 private companies.

The firm intends to continue building profit-generating products aimed at serving large financial institutions and institutional investors.

ProCap’s rapid Bitcoin purchase doubles down on its belief that Bitcoin represents the “new hurdle rate,” suggesting that companies unable to outperform Bitcoin’s growth should consider adding it to their balance sheets.

Columbus Circle Capital I is a blank-check company led by experienced financial executives and investment bankers, with plans to facilitate the merger and support ProCap’s growth as a public company.

Read Next:

Image: Shutterstock

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Market News and Data brought to you by Benzinga APIs

Most Popular

More from Author

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health...

Fed Gets Breathing Room as Labor Market Holds Firm

The monthly jobs report hit today (unusually, on a Thursday, due...

How California’s Housing Reforms Could Reshape US Cities Over the Next Decade

Things are moving fast these days. Texans for Reasonable Solutions, among others,...

Week Ahead – RBA, RBNZ Decisions and Fed Minutes Eyed as Trade Deals Awaited

July 9 tariff deadline looms as trade deals remain elusive Fed minutes...

Read Now

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health services employment, while private NFP surprises downside. With S&P Global monthly flat over the last six months through May, many key indicators followed by the NBER  Business Cycle Dating Committee (BCDC) are flat or falling...

Fed Gets Breathing Room as Labor Market Holds Firm

The monthly jobs report hit today (unusually, on a Thursday, due to the real and perfectly sensible holiday tomorrow blocking the typical Friday release) and the reaction was immediate. All the equity futures remain strong, but paradoxically, it can sometimes be a spike to the upside that...

How California’s Housing Reforms Could Reshape US Cities Over the Next Decade

Things are moving fast these days. Texans for Reasonable Solutions, among others, has helped push through a number of housing reforms in Texas. Maine has passed a couple of bills that should allow more step-change urban development, as I put it in the “Market Segmentation” post. And California has suddenly...

Week Ahead – RBA, RBNZ Decisions and Fed Minutes Eyed as Trade Deals Awaited

July 9 tariff deadline looms as trade deals remain elusive Fed minutes to be watched after positive jobs report RBA expected to cut but RBNZ to likely stay on hold OPEC+ to probably raise output again UK GDP, Canadian employment and Chinese CPI data also on tap The Race to the Finish...

The Fiscal Treadmill Is Speeding Up and Washington Keeps Jogging

As of 1980, the rolling 10-year and 20-year real GDP growth rates stood at 3.2% per annum and 3.5% per annum, respectively. Owing to a slight boost from the good parts of Reaganomics—sweeping deregulation, tax rate cuts, and sound money, which were partially offset by the long-term ills...

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera's Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy SolutionsDistinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have joined Immuthera's Scientific Advisory Board.Immuthera will continue expanding its Scientific Advisory Board over the coming months to build a truly world-class team.In collaboration...

Risk Assets Extend Gains but Low Volumes Could Skew Monday Open

Yesterday’s market action was driven by consecutive upside surprises in US (147K vs 110K exp) and data (50.8 vs 50.5 exp), fueling another wave of positive sentiment and pushing US equities into yet another frenzied rally. The reaction to the data was progressive but consistent, taking...

Risk-On Sentiment Fades as Tariffs Return to the Spotlight

Dollar surrenders gains posted after robust labour market report Trump celebrates US budget bill approval; scheduled to sign it today Most Fed members feel more comfortable as July rate cut is priced out Oil steadies near $66, gold rally retains momentum Thursday Proved to Be Rather EventfulWhile the US is celebrating...

Oil Prices Set to End the Week With a Modest Gain

prices were on course for a modest weekly gain today, buffeted by both headwinds and tailwinds, including OPEC+ policy, U.S. job numbers, and anticipation of President Trump’s next move on tariffs. At the time of writing, was trading at $68.58 per barrel, with West Texas Intermediate...

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer’s Trial Data – Cognition Therapeutics (NASDAQ:CGTX), InMed Pharmaceuticals (NASDAQ:INM)

Cognition Therapeutics Inc CGTX rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours. What Happened: The hike in Cognition Therapeutics’ stock price is attributed to the promising results from its Alzheimer’s drug, Zervimesine. The drug achieved a 95% efficacy...

Oil: How Traders Capitalized on Extreme Price Swings

The first half of the year saw significant oil price volatility influenced by U.S. trade policies, OPEC+ production decisions, and geopolitical tensions. Oil prices initially slumped due to new U.S. tariffs and increased OPEC+ output, leading traders to amass short positions. Prices later spiked in June due to Middle...

Gold Prices Slide as Strong NFP Data Undermines Fed Rate Cut Hopes

Strong NFP Data Put Downward Pressure on Gold Yesterday’s US (NFP) data showed that the labour market remains resilient, putting downward pressure on Gold (). In June, companies created more jobs than expected, and the unexpectedly dropped towards 4.1%. The overall report was better than expected, reducing...